Rentokil Initial PLC has a consensus price target of $25.33, established from looking at the 3 latest analyst ratings. The last 3 analyst ratings were released from Exane BNP Paribas, B of A Securities, and Oppenheimer on March 18, 2024, January 24, 2024, and May 22, 2023. With an average price target of $25.33 between Exane BNP Paribas, B of A Securities, and Oppenheimer, there's an implied -4.29% downside for Rentokil Initial PLC from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/18/2024 | RTO | Buy Now | Rentokil Initial | $26.47 | — | Exane BNP Paribas | — | — | Upgrade | Neutral → Outperform | Get Alert |
01/24/2024 | RTO | Buy Now | Rentokil Initial | $26.47 | 9.56% | B of A Securities | Simona Sarli | $40 → $29 | Downgrade | Buy → Neutral | Get Alert |
05/22/2023 | RTO | Buy Now | Rentokil Initial | $26.47 | 77.56% | Oppenheimer | Ian Zaffino | $40 → $47 | Maintains | Outperform | Get Alert |
The latest price target for Rentokil Initial (NYSE: RTO) was reported by Exane BNP Paribas on March 18, 2024. The analyst firm set a price target for $0.00 expecting RTO to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
The latest analyst rating for Rentokil Initial (NYSE: RTO) was provided by Exane BNP Paribas, and Rentokil Initial upgraded their outperform rating.
The last upgrade for Rentokil Initial PLC happened on March 18, 2024 when Exane BNP Paribas raised their price target to N/A. Exane BNP Paribas previously had a neutral for Rentokil Initial PLC.
The last downgrade for Rentokil Initial PLC happened on January 24, 2024 when B of A Securities changed their price target from $40 to $29 for Rentokil Initial PLC.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Rentokil Initial, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Rentokil Initial was filed on March 18, 2024 so you should expect the next rating to be made available sometime around March 18, 2025.
While ratings are subjective and will change, the latest Rentokil Initial (RTO) rating was a upgraded with a price target of $0.00 to $0.00. The current price Rentokil Initial (RTO) is trading at is $26.47, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.